Association Between α-Tocopherol, γ-Tocopherol, Selenium, and Subsequent Prostate Cancer

• Published in: JNCI : Journal of the National Cancer Institute Vol. 92; no. 24; pp. 2018 - 2023
• Main Authors: Helzlsouer, Kathy J., Huang, Han-Yao, Alberg, Anthony J., Hoffman, Sandra, Burke, Alyce, Norkus, Edward P., Morris, J. Steven, Comstock, George W.
• Format: Journal Article
• Language: English
• Published: Cary, NC Oxford University Press 20.12.2000; Oxford Publishing Limited (England)
• Subjects: Aged; Antioxidants; Biological and medical sciences; Case-Control Studies; Clinical trials; Humans; Incidence; Logistic Models; Male; Medical sciences; Middle Aged; Nephrology. Urinary tract diseases; Odds Ratio; Pathology; Prostate cancer; Prostatic Neoplasms - blood; Prostatic Neoplasms - etiology; Prostatic Neoplasms - prevention & control; Risk; Risk Factors; Selenium - administration & dosage; Selenium - blood; Tumors of the urinary system; Urinary tract. Prostate gland; Vitamin E; Vitamin E - administration & dosage; Vitamin E - blood; United States; North America; America; Human; Urinary system disease; Prostate disease; α-Tocopherol; Case control study; Malignant tumor; E-Vitamins; Epidemiology; Micronutrient; Prevention; Risk factor; Male genital diseases; Prostate; Public health
• ISSN: 0027-8874; 1460-2105; 1460-2105
• DOI: 10.1093/jnci/92.24.2018

Background: Selenium and α-tocopherol, the major form of vitamin E in supplements, appear to have a protective effect against prostate cancer. However, little attention has been paid to the possible role of γ-tocopherol, a major component of vitamin E in the U.S. diet and the second most common tocopherol in human serum. A nested case–control study was conducted to examine the associations of α-tocopherol, γ-tocopherol, and selenium with incident prostate cancer. Methods: In 1989, a total of 10 456 male residents of Washington County, MD, donated blood for a specimen bank. A total of 117 of 145 men who developed prostate cancer and 233 matched control subjects had toenail and plasma samples available for assays of selenium, α-tocopherol, and γ-tocopherol. The association between the micronutrient concentrations and the development of prostate cancer was assessed by conditional logistic regression analysis. All statistical tests were two-sided. Results: The risk of prostate cancer declined, but not linearly, with increasing concentrations of α-tocopherol (odds ratio highest versus lowest fifth = 0.65; 95% confidence interval = 0.32–1.32; Ptrend = .28). For γ-tocopherol, men in the highest fifth of the distribution had a fivefold reduction in the risk of developing prostate cancer than men in the lowest fifth (Ptrend = .002). The association between selenium and prostate cancer risk was in the protective direction with individuals in the top four fifths of the distribution having a reduced risk of prostate cancer compared with individuals in the bottom fifth (Ptrend = .27). Statistically significant protective associations for high levels of selenium and α-tocopherol were observed only when γ-tocopherol concentrations were high. Conclusions: The use of combined α- and γ- tocopherol supplements should be considered in upcoming prostate cancer prevention trials, given the observed interaction between α-tocopherol, γ-tocopherol, and selenium.